PuSH - HMGU Publikationen https://push-zb.helmholtz-munich.de PuSH - Publikationen-Server des Helmholtz Zentrums München de-de <![CDATA[Hofer, T.P. et al. Absence of CD4(+) and CD8(+) T cell expansion after primary multimodal treatment predicts early progression in inoperable stage III NSCLC. J. Clin. Oncol. 40:e20590 (2022)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66577&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66577&la=de Tue, 10 Jan 2023 00:00:00 +0000 <![CDATA[Haffner, I.* et al. HER2 expression, test deviations, and their impact on survival in metastatic gastric cancer: Results from the prospective multicenter VARIANZ study. J. Clin. Oncol. 39, 1468-1478 (2021)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=61686&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=61686&la=de Thu, 20 May 2021 00:00:00 +0000 <![CDATA[Burchert, A.* et al. Sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with FLT3-internal tandem duplication mutation (SORMAIN). J. Clin. Oncol. 38, 2993-3002 (2020)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59685&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=59685&la=de Tue, 28 Jul 2020 00:00:00 +0000 <![CDATA[Aubele, M. et al. uPA receptor and its interaction partners: Impact as potential therapeutic targets in triple-negative breast cancer. J. Clin. Oncol. 33:150 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48936&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=48936&la=de Fri, 01 Jul 2016 00:00:00 +0000 <![CDATA[Pastore, F. et al. Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia. J. Clin. Oncol. 32, 1586-1594 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31033&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31033&la=de Thu, 10 Apr 2014 00:00:00 +0000 <![CDATA[Icheva, V.* et al. Adoptive transfer of Epstein-Barr Virus (EBV) nuclear antigen 1-specific T cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J. Clin. Oncol. 31, 5-7 (2013)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=11082&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=11082&la=de Thu, 29 Nov 2012 00:00:00 +0000 <![CDATA[Icheva, V.* et al. Adoptive transfer of Epstein-Barr Virus (EBV) nuclear antigen 1-specific T cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J. Clin. Oncol. 31, 39-48 (2013)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=32909&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=32909&la=de Wed, 05 Nov 2014 00:00:00 +0000 <![CDATA[Li, Z.* et al. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: An international collaborative study. J. Clin. Oncol. 31, 1172-1181 (2013)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=28600&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=28600&la=de Fri, 06 Dec 2013 00:00:00 +0000 <![CDATA[Buck, K.* et al. Serum enterolactone and prognosis of postmenopausal breast cancer. J. Clin. Oncol. 29, 3730-3738 (2011)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4864&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4864&la=de Sat, 31 Dec 2011 00:00:00 +0000 <![CDATA[Dufour, A.* et al. Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. J. Clin. Oncol. 28, 570-577 (2010)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5140&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5140&la=de Fri, 31 Dec 2010 00:00:00 +0000 <![CDATA[Gires, O. & Bauerle, P.A.* EpCAM as a target in cancer therapy. J. Clin. Oncol. 28, E239-E240 (2010)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5850&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5850&la=de Thu, 25 Nov 2010 00:00:00 +0000 <![CDATA[Metzeler, K.H. et al. ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: A comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays. J. Clin. Oncol. 27, 5031-5038 (2009)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=2415&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=2415&la=de Thu, 31 Dec 2009 00:00:00 +0000 <![CDATA[van Glabbeke, M.* & Schlemmer, M. Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study. J. Clin. Oncol. 23, 5795-5804 (2005)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3698&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3698&la=de Fri, 30 Sep 2005 00:00:00 +0000 <![CDATA[Wendtner, C.-M.* et al. Response to Neoadjuvant Chemotherapy Combined with Regional Hyperthermia Predicts Long-Term Survival for Adult Patients with Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas. J. Clin. Oncol. 20, 3156-3164 (2002)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=10090&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=10090&la=de Mon, 09 Sep 2002 00:00:00 +0000 <![CDATA[Issels, R.D. et al. Ifosfamide Plus Etoposide Combined with Regional Hyperthermia in Patients with Locally Advanced Sarcomas: A Phase II Study. J. Clin. Oncol. (1990)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=18335&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=18335&la=de Mon, 31 Dec 1990 00:00:00 +0000